Company news

GeoVax Labs, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

GeoVax Announces Issuance of Hepatitis B Vaccine Patent

July 6, 2021

GeoVax Reports 2021 First Quarter Financial Results and Provides Corporate Update

May 5, 2021

GeoVax to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 and Provide Corporate Update

April 25, 2021

GeoVax Receives Notice of Allowance for Hepatitis B Vaccine Patent

March 31, 2021

GeoVax Reports 2020 Year-End Financial Results And Provides Corporate Update

March 22, 2021

GeoVax Expands and Strengthens Intellectual Property Portfolio

March 3, 2021

GeoVax Announces Closing of $10.3 Million Bought Deal Offering

February 10, 2021

GeoVax Announces Pricing of $9.0 Million Bought Deal Offering

February 7, 2021

GeoVax Awarded NIH Grant to Advance COVID-19 Vaccine Development

January 10, 2021

GeoVax Announces License Agreement With NIH to Support Continued Advancements in Vaccine Development

November 29, 2020

GeoVax Reports 2020 Third Quarter Financial Results and Provides Corporate Update

November 4, 2020

GeoVax Announces License Agreement with NIH to Support COVID-19 Vaccine Development

October 25, 2020

GeoVax Announces Closing of $12.8 Million Public Offering and Uplisting to Nasdaq

September 28, 2020

GeoVax Announces Pricing of $12.8 Million Public Offering; Uplisting to Nasdaq and Reverse Stock Split

September 23, 2020

GeoVax Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate Against Marburg Virus Showing 100% Protection

September 2, 2020

GeoVax Appoints Mark J. Newman, Ph.D. Chief Scientific Officer

August 25, 2020

GeoVax Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients

August 23, 2020

GeoVax Announces Collaboration for Development of Sudan Ebolavirus and Marburg Virus Vaccines

August 12, 2020

GeoVax Reports 2020 Second Quarter Financial Results and Provides Corporate Update

August 9, 2020

GeoVax Announces Closing of $1 Million Private Placement

June 28, 2020

GeoVax Labs, Inc. Announces Approval for Trading on OTCQB Venture Market

June 3, 2020

GeoVax Reports 2020 First Quarter Financial Results and Provides Corporate Update

May 5, 2020

GeoVax and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 (COVID-19) Vaccine Development

April 29, 2020

GeoVax Reports 2019 Year-End Financial Results And Provides Corporate Update

March 24, 2020

GeoVax Progresses in Coronavirus (COVID-19) Vaccine Development Program

March 17, 2020

GeoVax Provides Update on Coronavirus (COVID-19) Vaccine Development Program

March 3, 2020

GeoVax Announces Reverse Stock Split

January 22, 2020

GeoVax Reports 2019 Third Quarter Financial Results and Provides Corporate Update

November 6, 2019

← Newer news releases

Calls

The 5 newest of 21 calls. Every call is listed under its year.

Decks

The 5 newest of 6 decks. Every deck is listed under its year.